CONSTANCE ROSENBALM: Open Payments
NPI 1669856662 · NEW TAZEWELL, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$254 in 19 payments from 4 companies in 2025. Trend: 2023 $55 · 2024 $82 · 2025 $254
Food & beverage: $254
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 15 | $182 |
| PFIZER INC. | 2 | $37 |
| Vanda Pharmaceuticals Inc. | 1 | $17 |
| GlaxoSmithKline, LLC. | 1 | $17 |
Products named: CAPLYTA, NURTEC ODT, HETLIOZ, TRELEGY ELLIPTA.
Industry payments across TN — which companies pay providers there.
